KDIGO2012EN
KDIGO Clinical Practice Guideline for Acute Kidney Injury
Zusammenfassung
Diagnosis, prevention, and management of AKI
Kerninformationen
KDIGO Controversies Conference on Acute Kidney Injury revisited KDIGO AKI nomenclature and diagnostic criteria, discussed AKI risk stratification and the role of biomarkers in this process, examined the role of resuscitation fluids and nephrotoxins in the critically ill, and addressed timing and mod...
outlined in the KDIGO 2012 AKI guideline have been further investigated in recent randomized controlled trials (RCTs). Results of RCTs have provided new data, in particular related to early resuscitation, fluid therapy, and strategies for prevention of contrast-associated AKI and nephrotoxic AKI, a...
equity will be considered within the general guidelines and where they focus on disadvantaged populations. Equity considerations will be explicitly incorporated within evidence-to-decision 2 framework by assessing the potential impact of interventions on equity and incorporating equity consideratio...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
KDIGO2026
KDIGO 2026 Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Acute Kidney Injury (AKI) and Acute Kidney Disease (AKD) - Public Review Draft
KDIGO2012
KDIGO 2012: Acute Kidney Injury
KDIGO2024
KDIGO 2024: CKD Evaluation and Management
KDIGO2024
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
KDIGO2024
KDIGO 2024 Clinical Practice Guideline on Evaluation and Management of Chronic Kidney Disease
KDIGO2024
KDIGO Guideline-Recommended Disease-Modifying Therapies for Cardiorenal Syndrome
KDIGO2022
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
KDIGO2021